-
公开(公告)号：EP3585392A1
公开(公告)日：2020-01-01
申请号：EP18708929.7
申请日：2018-02-21
发明人： SAND, Michael Steven , ROSENBROCK, Holger , GIOVANNINI, Riccardo , ADACHI, Masashi , BETZEMEIER, Bodo , BRODMANN, Tobias , KAMATA, Takayuki , KAWABATA, Yohei , ITO, Masanori , MARCKART, Daniel Jens , NAKATANI, Manabu , WERTHMANN, Ulrike
IPC分类号： A61K31/519 , C07D487/04 , A61P25/18
-
公开(公告)号：EP3174533A1
公开(公告)日：2017-06-07
申请号：EP15742300.5
申请日：2015-07-29
CPC分类号： A61K9/0056 , A61K9/2009 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K9/2081 , A61K9/2095 , A61K31/4184
摘要： A process for the preparation of an oral disintegrating tablet comprising the antihypertensive telmisartan and the tablet obtained by the process.
摘要翻译： 一种制备包含抗高血压替米沙坦和通过该方法获得的片剂的口腔崩解片的方法。
-
公开(公告)号：EP3261621A1
公开(公告)日：2018-01-03
申请号：EP16705964.1
申请日：2016-02-24
发明人： BEHREND, Olaf , LINKH, Thomas , NAKATANI, Manabu
IPC分类号： A61K9/14 , A61K9/20 , A61K31/4184
CPC分类号： A61K9/2095 , A61K9/143 , A61K9/145 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K31/4184
摘要： A process for the preparation of an immediate release tablet comprising the antihypertensive telmisartan and the tablet obtained by the process.
-
公开(公告)号：EP1545467A1
公开(公告)日：2005-06-29
申请号：EP03750572.4
申请日：2003-09-18
IPC分类号： A61K9/16 , A61K9/20 , A61K31/4184
CPC分类号： A61K9/209 , A61K9/1617 , A61K9/1623 , A61K9/1641 , A61K9/1652 , A61K9/2013 , A61K9/2018 , A61K9/2031 , A61K9/2054 , A61K31/4184
摘要： The invention relates to new solid pharmaceutical compositions comprising the angiotensin II receptor antagonist telmisartan, a basic agent, a surfactant or emulsifier and a water-soluble diluent, e.g. in form of granules or in form of a powder, as well as solid oral formulations ready for use/ingestion, e.g. capsule and tablet formulations made from said pharmaceutical compositions, and methods for producing said compositions and formulations making use of a fluid-bed granulation process or of a spray-drying process.
-
公开(公告)号：EP4229051A1
公开(公告)日：2023-08-23
申请号：EP21786982.5
申请日：2021-10-11
发明人： BAER, Katrin , BARTA, Albert Josef , BODENBACH, Gisela , GAO, Joe Ju , GRIMM, Julia Regina , NORDSTROM, Fredrik, Lars , WIESE, Michael , YANG, Bing-Shiou , NAKATANI, Manabu , ADACHI, Masashi , EGUSA, Kenji , MESSERSCHMID, Roman Christian , SCHROEDER, Daniela Maria
IPC分类号： C07D413/04 , A61K31/42 , A61P25/18
-
公开(公告)号：EP3463309A1
公开(公告)日：2019-04-10
申请号：EP17726262.3
申请日：2017-05-24
IPC分类号： A61K9/20 , A61K9/24 , A61K31/4184 , A61K31/4422 , A61K31/495
-
公开(公告)号：EP1959934A2
公开(公告)日：2008-08-27
申请号：EP06819653.4
申请日：2006-11-22
IPC分类号： A61K9/20 , A61K31/4184 , A61K31/54
CPC分类号： A61K9/209 , A61K31/4184 , A61K31/54 , A61K31/549 , A61K45/06 , A61K2300/00
摘要： The invention relates to a bilayer pharmaceutical tablet comprising a first layer containing 3 to 50 wt.% of telmisartan dispersed in a dissolving tablet matrix and a second layer containing a diuretic in a disintegrating tablet matrix as well as a processes for producing same.
-
公开(公告)号：EP3174533B1
公开(公告)日：2019-09-11
申请号：EP15742300.5
申请日：2015-07-29
IPC分类号： A61K9/00 , A61K9/20 , A61K31/4184
-
公开(公告)号：EP1545467B1
公开(公告)日：2007-09-12
申请号：EP03750572.4
申请日：2003-09-18
IPC分类号： A61K9/16 , A61K9/20 , A61K31/4184
CPC分类号： A61K9/209 , A61K9/1617 , A61K9/1623 , A61K9/1641 , A61K9/1652 , A61K9/2013 , A61K9/2018 , A61K9/2031 , A61K9/2054 , A61K31/4184
摘要： The invention relates to new solid pharmaceutical compositions comprising the angiotensin II receptor antagonist telmisartan, a basic agent, a surfactant or emulsifier and a water-soluble diluent, e.g. in form of granules or in form of a powder, as well as solid oral formulations ready for use/ingestion, e.g. capsule and tablet formulations made from said pharmaceutical compositions, and methods for producing said compositions and formulations making use of a fluid-bed granulation process or of a spray-drying process.
-
公开(公告)号：EP1448204A1
公开(公告)日：2004-08-25
申请号：EP02802290.3
申请日：2002-10-08
CPC分类号： A61K9/0095 , A61K9/2018 , A61K31/55
摘要： The present invention refers to a new formulation of epinastine in form of a powder (dry syrup) to be mixed with water prior to use. Epinastine can be used either as free base or as a pharmaceutically acceptable salt thereof. Epinastine among others is for treating allergies, pain, in particular chronic pain and inflammation caused pain, migraine, asthma, rhinitis, conjunctivitis and/or bronchitis. In particular, the formulation is for treating allergies, dermatitis, rhinitis, conjunctivitis, bronchitis and asthma.
-
-
-
-
-
-
-
-
-
搜索结果
10 条记录 (耗时 0.011 秒)
